9267 — Genky Drugstores Co Income Statement
0.000.00%
- ¥97bn
- ¥123bn
- ¥185bn
- 84
- 38
- 87
- 82
Annual income statement for Genky Drugstores Co, fiscal year end - June 20th, JPY millions except per share, conversion factor applied.
2020 June 20th | 2021 June 20th | 2022 June 20th | 2023 June 20th | 2024 June 20th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 123,603 | 142,376 | 154,640 | 169,059 | 184,860 |
Cost of Revenue | |||||
Gross Profit | 26,712 | 30,289 | 30,954 | 34,554 | 37,621 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 119,796 | 136,020 | 148,969 | 162,735 | 176,296 |
Operating Profit | 3,808 | 6,356 | 5,670 | 6,324 | 8,564 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4,032 | 6,663 | 6,084 | 6,704 | 8,803 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,755 | 4,832 | 4,421 | 4,765 | 6,325 |
Net Income Before Extraordinary Items | |||||
Net Income | 2,755 | 4,832 | 4,421 | 4,765 | 6,325 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,755 | 4,832 | 4,421 | 4,764 | 6,324 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 103 | 158 | 146 | 166 | 219 |
Dividends per Share |